We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
+61.75%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$936M
AUM Growth
+$589M
(+170%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
36.25%
Top 10 Holdings %
Top 10 Hldgs %
80.61%
Holding
67
New
28
Increased
19
Reduced
5
Closed
15
Top Buys
| 1 |
Dianthus Therapeutics
DNTH
|
+$122M |
| 2 |
Perspective Therapeutics
CATX
|
+$37.6M |
| 3 |
ORKA
Oruka Therapeutics
ORKA
|
+$29.9M |
| 4 |
JBIO
Jade Biosciences
JBIO
|
+$20.3M |
| 5 |
Enliven Therapeutics
ELVN
|
+$18.3M |
Top Sells
| 1 |
CG Oncology
CGON
|
+$10.4M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$8.35M |
| 3 |
McKesson
MCK
|
+$7.81M |
| 4 |
Agilent Technologies
A
|
+$5.65M |
| 5 |
Pfizer
PFE
|
+$5.07M |
Sector Composition
| 1 | Healthcare | 99.4% |
| 2 | Consumer Staples | 0.39% |
| 3 | Consumer Discretionary | 0.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Savara
SVRA
$1.19B
| $262K | 0.03% |
+50,000
| New | +$278K |
|
52
Trevi Therapeutics
TRVI
$2.58B
| $171K | 0.02% |
+13,320
| New | +$149K |
|
|
53
Agilent Technologies
A
$38B
| – | – |
-41,500
| Closed | -$5.65M |
|
54
Acadia Healthcare
ACHC
$2.97B
| – | – |
-169,000
| Closed | -$2.4M |
|
|
55
Alnylam Pharmaceuticals
ALNY
$37.3B
| – | – |
-21,000
| Closed | -$8.35M |
|
56
Cigna
CI
$78.8B
| – | – |
-11,600
| Closed | -$3.19M |
|
57
Cencora
COR
$57.7B
| – | – |
-9,400
| Closed | -$3.17M |
|
58
Danaher
DHR
$142B
| – | – |
-17,000
| Closed | -$3.89M |
|
59
HealthEquity
HQY
$7.95B
| – | – |
-16,900
| Closed | -$1.55M |
|
60
Insmed
INSM
$23.8B
| – | – |
-17,700
| Closed | -$3.08M |
|
61
IQVIA
IQV
$34.5B
| – | – |
-4,400
| Closed | -$992K |
|
62
Integer Holdings
ITGR
$3.24B
| – | – |
-29,800
| Closed | -$2.34M |
|
|
63
McKesson
MCK
$93.2B
| – | – |
-9,520
| Closed | -$7.81M |
|
|
NVO
64
Novo Nordisk
NVO
$224B
| – | – |
-67,300
| Closed | -$3.42M |
|
|
65
Pfizer
PFE
$141B
| – | – |
-203,600
| Closed | -$5.07M |
|
66
Thermo Fisher Scientific
TMO
$199B
| – | – |
-6,700
| Closed | -$3.88M |
|
67
Waters Corp
WAT
$36.8B
| – | – |
-8,100
| Closed | -$3.08M |
|
Similar funds
NM
LM
IF
PWAM
CM
LJAC
PO
SH